(Q51778586)

English

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

scientific article published on 14 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

0 references

1 reference

based on heuristic

inferred from title

Laurent Crenier

object named as

L Crenier

9

0 references

Herman Waldmann

object named as

H Waldmann

12

0 references

author name string

B Keymeulen

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

M Walter

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

C Mathieu

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

L Kaufman

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

F Gorus

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

R Hilbrands

6

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

E Vandemeulebroucke

7

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

U Van de Velde

8

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

C De Block

10

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

S Candon

11

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

A G Ziegler

13

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

L Chatenoud

14

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

D Pipeleers

15

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

publication date

14 January 2010

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

53

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

614-623

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

https://scigraph.springernature.com/pub.10.1007/s00125-009-1644-9

0 references

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1644-9

21 January 2018

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes--2008.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The beta cell population in type 1 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of type 1 diabetes: the time has come.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulation with human recombinant autoantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro characterization of five humanized OKT3 effector function variant antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic beta cells in insulin-dependent diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD3-specific antibodies: a portal to the treatment of autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20225393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-009-1644-9

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/20225393

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51778586&oldid=1766984120"